OptiNose Competitors and Similar CompaniesClear all

OptiNose's competitors and similar companies include Intersect ENT.
OptiNose
OptiNose
OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
Intersect ENT
Intersect ENT
Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company.
Founding Date
Founding Date
2000
Founding Date
2003
Type
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Morrisville, US HQ
Oslo, NO
Swindon, GB
Locations
Menlo Park, US HQ
Employees
Employees
2048% decrease
Employees
4337% increase

Financial

Revenue (est.)
Revenue (est.)
$78.2m (FY, 2024)
Revenue (est.)
$106.7m (FY, 2021)
Cost of goods
Cost of goods
$7.2m (FY, 2024)
Cost of goods
$30m (FY, 2021)
Gross profit
Gross profit
$71m (FY, 2024)
Gross profit
$76.7m (FY, 2021)
Net income
Net income
($21.5m) (FY, 2024)
Net income
($159.6m) (FY, 2021)

Operating

Patents (US)
Patents (US)
43 (Jun, 2017)
Patents (US)
30 (FY, 2016)
Trademarks (US)
Trademarks (US)
3 (Jun, 2017)
Trademarks (US)
4 (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 120.5m
Total funding raised
$ 102.9m
For sources of this data, please see the company profile

View Company Profiles

Intersect ENT
HQ
Menlo Park, US

Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company.

View company